Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2016

01.03.2016 | Original Article

Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells

verfasst von: Naser Amirizadeh, Arezoo Oodi, Roya Mehrasa, Mahin Nikougoftar

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Expansion of umbilical cord blood-derived CD34+ cells can potentially provide them in numbers sufficient for clinical applications in adult humans. In this study apoptosis rate of expanded cells, mRNA expression and promoter methylation status of DAPK1 were evaluated during cord blood hematopoietic stem cell (CB-HSC) ex vivo expansion using cytokines and a co-culture system with mesenchymal stromal cells (MSCs). Ex vivo cultures of CB-HSCs were performed in three culture conditions for 14 days: cytokines with MSCs feeder layer, cytokines without MSCs feeder layer and co-culture with MSCs feeder layer without cytokine. Total number of cells, CD34+ cells and colony forming unit assay were performed during expansion. Flow cytometric analysis by propidium iodide was performed to detection of apoptosis rate in expanded cells. Methylation status of the DAPK1 gene promoter was analyzed using methylation specific PCR, and DAPK1 mRNA expression was evaluated by real time-PCR. Maximum CB-CD34+ cells expansion was observed in day 10 of expansion. The highest apoptosis rate was observed in cytokine culture without feeder layer that showed significant difference with co-culture condition. The data showed that ex vivo expansion of CD34+ cells in all three culture conditions after 10 days resulted in, significant increased expression of DAPK1, also a significant difference between co-culture without cytokine and two other cytokine culture was observed (p < 0.01). DAPK1gene promoter of expanded CD34+ cells at days 5, 10 and 14 of culture remained in unmethylated form similar to fresh CD34+ cells. Expression of DAPK1 in hematopoietic cells was increased during 10 days expansion of CD34+ cells. Also no methylation of DAPK1 promoter was observed; otherwise it would be capable of initiating some leukemic cell progression or disruption in hematopoietic regeneration.
Literatur
1.
Zurück zum Zitat Delaney C, Ratajczak MZ, Laughlin MJ (2010) Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev Hematol 3:273–283PubMedCentralCrossRefPubMed Delaney C, Ratajczak MZ, Laughlin MJ (2010) Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev Hematol 3:273–283PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611–1618PubMed Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611–1618PubMed
4.
Zurück zum Zitat Dahlberg A, Delaney C, Bernstein ID (2011) Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 23:234–245 Dahlberg A, Delaney C, Bernstein ID (2011) Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 23:234–245
5.
Zurück zum Zitat Patricia D, Conrad SG (1998) Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J Leuk Biol 64:147–155 Patricia D, Conrad SG (1998) Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J Leuk Biol 64:147–155
6.
Zurück zum Zitat Oguro H, Iwama A (2007) Life and death in hematopoietic stem cells. Curr Opin Immunol 19:503–509CrossRefPubMed Oguro H, Iwama A (2007) Life and death in hematopoietic stem cells. Curr Opin Immunol 19:503–509CrossRefPubMed
7.
Zurück zum Zitat Alenzi FQ, Alenazi BQ, Ahmad SY, Salem ML, Al-Jabri AA, Wyse RK (2009) The haemopoietic stem cell: between apoptosis and self renewal. Yale J Biol Med 82:7–18PubMedCentralPubMed Alenzi FQ, Alenazi BQ, Ahmad SY, Salem ML, Al-Jabri AA, Wyse RK (2009) The haemopoietic stem cell: between apoptosis and self renewal. Yale J Biol Med 82:7–18PubMedCentralPubMed
8.
Zurück zum Zitat Cohen O, Kimchi A (2001) DAP-kinase from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ 8:6–15CrossRefPubMed Cohen O, Kimchi A (2001) DAP-kinase from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ 8:6–15CrossRefPubMed
9.
10.
Zurück zum Zitat Hopfer O, Komor M, Koehler IS, Schulze M, Hoelzer D, Thiel E, Hofmann WK (2007) DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation. Exp Hematol 35:712–723CrossRefPubMed Hopfer O, Komor M, Koehler IS, Schulze M, Hoelzer D, Thiel E, Hofmann WK (2007) DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation. Exp Hematol 35:712–723CrossRefPubMed
11.
Zurück zum Zitat Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL (2000) Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9:841–848CrossRefPubMed Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL (2000) Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9:841–848CrossRefPubMed
12.
Zurück zum Zitat Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG, Sidransky D (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60:892–895PubMed Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG, Sidransky D (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60:892–895PubMed
13.
Zurück zum Zitat Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 10:3441–3454PubMedCentralCrossRefPubMed Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 10:3441–3454PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Gade P, Singh AK, Roy SK, Reddy SP, Kalvakolanu DV (2009) Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated DAPK1 in human cancers and cancer cells. Int J Cancer 125:1566–1574PubMedCentralCrossRefPubMed Gade P, Singh AK, Roy SK, Reddy SP, Kalvakolanu DV (2009) Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated DAPK1 in human cancers and cancer cells. Int J Cancer 125:1566–1574PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Tung SS, Parmar S, Robinson SN, De Lima M, Shpall EJ (2010) Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol 23:245–257CrossRefPubMed Tung SS, Parmar S, Robinson SN, De Lima M, Shpall EJ (2010) Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol 23:245–257CrossRefPubMed
16.
Zurück zum Zitat Yildirim S, Boehmler Am, Kanz L, Mohle R (2005) Expansion of cord blood CD34+ hematopoietic progenitor cells in co-culture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture. Bone Marrow Transpl 36:71–79CrossRef Yildirim S, Boehmler Am, Kanz L, Mohle R (2005) Expansion of cord blood CD34+ hematopoietic progenitor cells in co-culture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture. Bone Marrow Transpl 36:71–79CrossRef
17.
Zurück zum Zitat Traycoff CM, Orazi A, Ladd AC (1998) Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol 26:53–62PubMed Traycoff CM, Orazi A, Ladd AC (1998) Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol 26:53–62PubMed
18.
Zurück zum Zitat Wulf-Goldenberg A, Eckert K, Fichtner I (2008) Cytokine-pretreatment of CD34+ cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice. Eur J Cell Biol 87:69–80CrossRefPubMed Wulf-Goldenberg A, Eckert K, Fichtner I (2008) Cytokine-pretreatment of CD34+ cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice. Eur J Cell Biol 87:69–80CrossRefPubMed
19.
Zurück zum Zitat Alvarado-Moreno A, Chávez-González A, Cérbulo A, Arriaga L, Mayani H (2010) In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood. Hematology 15:11–20CrossRefPubMed Alvarado-Moreno A, Chávez-González A, Cérbulo A, Arriaga L, Mayani H (2010) In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood. Hematology 15:11–20CrossRefPubMed
20.
Zurück zum Zitat Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, Sung KW, Koo HH, Oh W, Yang YS, Yang SE (2006) Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 85:212–225CrossRefPubMed Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, Sung KW, Koo HH, Oh W, Yang YS, Yang SE (2006) Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 85:212–225CrossRefPubMed
21.
Zurück zum Zitat Da Silva CL, Gonçalves R, Crapnell KB, Cabral JM, Zanjani ED, Almeida-Porada G (2005) A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol 33:828–835CrossRefPubMed Da Silva CL, Gonçalves R, Crapnell KB, Cabral JM, Zanjani ED, Almeida-Porada G (2005) A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol 33:828–835CrossRefPubMed
22.
23.
24.
Zurück zum Zitat Wagner W, Saffrich R, Wirkner U (2005) Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction. Stem Cells 23:1180–1191CrossRefPubMed Wagner W, Saffrich R, Wirkner U (2005) Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction. Stem Cells 23:1180–1191CrossRefPubMed
25.
Zurück zum Zitat Zou Jing, Zou Ping, Wang Jie (2012) Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Ann Hematol 91(6):813–823PubMedCentralCrossRefPubMed Zou Jing, Zou Ping, Wang Jie (2012) Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Ann Hematol 91(6):813–823PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Wei Z, Chen N, Guo H, Wang X, Xu F, Ren Q, Lu S, Liu B, Zhang L, Zhao H (2009) Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells. J Exp Clin Cancer Res 28:141–145PubMedCentralCrossRefPubMed Wei Z, Chen N, Guo H, Wang X, Xu F, Ren Q, Lu S, Liu B, Zhang L, Zhao H (2009) Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells. J Exp Clin Cancer Res 28:141–145PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21–33CrossRefPubMed Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21–33CrossRefPubMed
30.
Zurück zum Zitat Greco M, D’Alò F, Scardocci A, Criscuolo M, Fabiani E, Guidi F, Di Ruscio A, Migliara G, Pagano L, Fianchi L, Chiusolo P, Hohaus S, Leone G, Voso MT (2010) Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms. Blood Cells Mol Dis 45:181–185CrossRefPubMed Greco M, D’Alò F, Scardocci A, Criscuolo M, Fabiani E, Guidi F, Di Ruscio A, Migliara G, Pagano L, Fianchi L, Chiusolo P, Hohaus S, Leone G, Voso MT (2010) Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms. Blood Cells Mol Dis 45:181–185CrossRefPubMed
31.
Zurück zum Zitat Qian J, Yao DM, Lin J, Wang YL, Han LX, Xu WR, Wu CY (2010) Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome. Int J Lab Hematol 32:74–81CrossRefPubMed Qian J, Yao DM, Lin J, Wang YL, Han LX, Xu WR, Wu CY (2010) Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome. Int J Lab Hematol 32:74–81CrossRefPubMed
Metadaten
Titel
Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells
verfasst von
Naser Amirizadeh
Arezoo Oodi
Roya Mehrasa
Mahin Nikougoftar
Publikationsdatum
01.03.2016
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 1/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0545-y

Weitere Artikel der Ausgabe 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.